NEWTON, Mass. (AP) — NEWTON, Mass. (AP) — Karyopharm Therapeutics Inc. (KPTI) on Tuesday reported a loss of $32.1 million in its third quarter.

The Newton, Massachusetts-based company said it had a loss of 26 cents per share.

The results beat Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 27 cents per share.

The pharmaceutical company posted revenue of $38.8 million in the period, also beating Street forecasts. Four analysts surveyed by Zacks expected $37.9 million.

Karyopharm Therapeutics expects full-year revenue in the range of $145 million to $155 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on KPTI at https://www.zacks.com/ap/KPTI